284 Comprehensive quantification of fuel use by the failing and nonfailing human heart.
https://science.sciencemag.org/content/370/6514/364
283 The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages.
https://immunology.sciencemag.org/content/5/51/eaaz1974
282 Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease.
https://www.pnas.org/content/117/37/23113
281 Genetic and functional insights into the fractal structure of the heart.
https://www.nature.com/articles/s41586-020-2635-8
280 In vivo high-loading peptide nanoparticle administration prevented thrombosis and myocardial injury without causing bleeding in mice.
https://stm.sciencemag.org/content/12/552/eaaz7287
279 Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
https://www.nejm.org/doi/full/10.1056/NEJMoa1915928
278 Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and rats.
https://stm.sciencemag.org/content/12/540/eaaw3172
277 An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs.
https://stm.sciencemag.org/content/12/538/eaat9683
276 Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy.
https://stm.sciencemag.org/content/12/530/eaay8329
275 Targeted anti–IL-1β platelet microparticles for cardiac detoxing and repair.
https://advances.sciencemag.org/content/6/6/eaay0589
|
